Gao et al. developed PEGylated immunoliposomes with anti-HER2 Fab’ (PIL) by extrusion and a lyophilized PIL (LPIL) for anti-RhoA siRNA delivery to HER2-overexpressing cancer cells. This evidence concerns the gene ERBB2 and cancer.